Agena Bioscience - About the company
Agena Bioscience is an acquired company based in San Diego (United States), founded in 2014. It operates as a Genetic analysis technology company providing rapid and accurate solutions for research. Agena Bioscience has raised an undisclosed amount in funding, with last known valuation of $*****. The company has 283 active competitors, including 34 funded and 23 that have exited. Its top competitors include companies like DNAnexus, Fabric Genomics and Twin Strand Bio.
Company Details
Genetic analysis technology company providing rapid and accurate solutions for research. The company delivers innovative tools and services for genetic analysis, focusing on applications like pharmacogenetics, liquid biopsy, mutation profiling, hereditary genetics, methylation analysis, and sample integrity. They offer assays and certified service providers, supporting research labs with product literature and expert support. Their MassARRAY System aids genetic research with minimal bioinformatics analysis, maximum productivity, flexible biomarker detection, broad multiplexing, and efficient processes. The company's solutions advance precision medicine, enabling earlier detection and treatment of diseases. They provide a platform for highly multiplexed results in a simple workflow, serving the research community with cutting-edge technology and comprehensive support.
- Website
- www.agenabio.com/
- Social
- Registered Address
- San Diego, California
Key Metrics
Founded Year
2014
Location
San Diego, United States
Stage
Acquired
Latest Funding Round
Last Known Valuation
$***** as on Sep 27, 2021
Investors
Ranked
8th among 283 active competitors
Employee Count
155 as on Aug 31, 2026
Exit Details
Acquired by Mesa Labs (Sep 27, 2021)
Legal entities associated with Agena Bioscience
Agena Bioscience is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
AGENA BIOSCIENCE, INC. CIN: 222309890 , United States, Active | Jan 31, 2024 | - | - | - |
Agena CIN: 40103910202 , Latvia, Deadpooled | Jun 29, 2015 | €0 - €1M (As on Dec 31, 2017) | - | - |
BIOSCIENCES ACQUISITION COMPANY CIN: 465602734 , United States, Active | Dec 31, 1999 | - | 147 (As on Dec 31, 2021) | - |
Agena Bioscience's acquisition details
Click here to take a look at Agena Bioscience's acquisition in detail
Sign up to download Agena Bioscience's company profile
Agena Bioscience's funding and investors
Agena Bioscience has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Jan 01, 2018 for $*****. 1 investor participated in its latest round. Agena Bioscience has 2 institutional investors.
Here is the list of recent funding rounds of Agena Bioscience:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 01, 2018 | 7973002 | Grant (prize money) | 2849978 | 6098100 | 6522641 | 3047919 |
Access funding benchmarks and valuations. Sign up today!View details of Agena Bioscience's funding rounds and investors
Agena Bioscience's founders and board of directors
Founder? Claim ProfileAgena Bioscience's employee count trend
Agena Bioscience has 155 employees as of Aug 26. Here is Agena Bioscience's employee count trend over the years:
Uncover Agena Bioscience's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Agena Bioscience's Competitors and alternates
Top competitors of Agena Bioscience include DNAnexus, Fabric Genomics and Twin Strand Bio. Here is the list of Top 10 competitors of Agena Bioscience, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  DNAnexus 2009, Mountain View (United States), Series H | Provider of cloud-based genome informatics & data management platform | $473M | 71/100 | |
2nd | Fabric Genomics 2009, Oakland (United States), Acquired | AI-based disease diagnosis and genomic analysis tool for providers | $32.8M | 67/100 | |
3rd |  Twin Strand Bio 2015, Seattle (United States), Series B | Developer of DNA sequencing technology to identify genomic mutations | $84M | 66/100 | |
4th | BC Platforms 1997, Zurich (Switzerland), Series D | Provider of a platforms for genomic data analysis and management | $47.1M | 58/100 | |
5th | Genomenon 2014, Ann Arbor (United States), Series C | Provider of software, data, and services for genomic information analysis | $42.9M | 57/100 | |
6th |  Broken String Biosciences 2020, Cambridge (United Kingdom), Series A | Developer of biopharmaceutical products & cell therapies by using genome sequencing data | $15M | 55/100 | |
7th | Seven Bridges Genomics 2009, Cambridge (United States), Acquired | Biomedical data analysis company accelerating healthcare research with software and analytics | $113M | 54/100 | |
8th | Agena Bioscience 2014, San Diego (United States), Acquired | Genetic analysis technology company providing rapid and accurate solutions for research | - | 49/100 | |
9th |  Strand NGS 2000, Bengaluru (India), Unfunded | Provider of next-generation sequencing analysis software | - | - | 48/100 |
10th | Provider of kits and software that enable detailed analysis of the complete transcriptome | - | 47/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Agena Bioscience's competitors? Click here to see the top ones
Agena Bioscience's Investments and acquisitions
Agena Bioscience has made no investments or acquisitions yet.
Reports related to Agena Bioscience
Here is the latest report on Agena Bioscience's sector:
News related to Agena Bioscience
Filter this listMedia has covered Agena Bioscience for 1 event in last 1 year, It was about company updates.
•
Agena Bioscience Announces Launch of the CFTR 100+ Panel on the MassARRAY® SystemBusiness Wire•Mar 30, 2026•Agena Bioscience
•
Landmark Patient Trial To Use Genetic Testing To Personalise TreatmentsmyDNA•Jun 19, 2025•myDNA, Agena Bioscience
•
Glasgow Uni Leads Genetic Trial to Improve NHS PrescribingEuropaWire•Jun 18, 2025•NHSGGC, University of Glasgow, NHS Scotland, myDNA and 2 others
•
Precision for Medicine partners with Agena Bioscience to fill NGS testing gapsLabPulse.com•Nov 21, 2024•Precision for Medicine, Agena Bioscience
•
Mission Bio Appoints Roman Haehn as Chief Commercial Officer to Drive Market ExpansionBioSpace•Jul 11, 2024•Mission Bio, Agena Bioscience
•
Agena Bioscience and nRichDX Announce Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy AnalytesTullahoma News•Apr 15, 2023•Agena Bioscience, nRichDX
•
•
Ethos Labs, Agena Biosciences Partner on SARS-CoV-2 Variant IdentificationGenomeWeb•Apr 13, 2021•Ethos-Labs, Agena Bioscience
•
Agena Inks MassArray Distribution Deal for Middle East, Africa, Central Asia360Dx•Mar 10, 2021•Agena Bioscience, Alliance Global FZ
•
Agena Bioscience Launches New Panel for Detection and Discrimination of SARS-CoV-2 Variants of ConcernPR Newswire•Mar 01, 2021•Agena Bioscience
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Agena Bioscience
Explore our recently published companies
- Durham Taxis - Unfunded company
- LDN Transfers - London based, 2022 founded, Unfunded company
- English with Lynn - United Kingdom based, Unfunded company
- LCD Displeje - Czech Republic based, Unfunded company
- Eurotimesystems - 1990 founded, Unfunded company
- Lcd4Laptop - Wembley based, Unfunded company
